218 related articles for article (PubMed ID: 12810581)
1. Muscarinic receptors control glucagon-like peptide 1 secretion by human endocrine L cells.
Anini Y; Brubaker PL
Endocrinology; 2003 Jul; 144(7):3244-50. PubMed ID: 12810581
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic receptors control postprandial release of glucagon-like peptide-1: in vivo and in vitro studies in rats.
Anini Y; Hansotia T; Brubaker PL
Endocrinology; 2002 Jun; 143(6):2420-6. PubMed ID: 12021207
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of glucagon-like peptide-1 secretion by muscarinic agonist in a murine intestinal endocrine cell line.
Abello J; Ye F; Bosshard A; Bernard C; Cuber JC; Chayvialle JA
Endocrinology; 1994 May; 134(5):2011-7. PubMed ID: 8156901
[TBL] [Abstract][Full Text] [Related]
4. Regulation of glucagon-like peptide-1 synthesis and secretion in the GLUTag enteroendocrine cell line.
Brubaker PL; Schloos J; Drucker DJ
Endocrinology; 1998 Oct; 139(10):4108-14. PubMed ID: 9751489
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like-peptide-1 secretion from canine L-cells is increased by glucose-dependent-insulinotropic peptide but unaffected by glucose.
Damholt AB; Buchan AM; Kofod H
Endocrinology; 1998 Apr; 139(4):2085-91. PubMed ID: 9528997
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms underlying metformin-induced secretion of glucagon-like peptide-1 from the intestinal L cell.
Mulherin AJ; Oh AH; Kim H; Grieco A; Lauffer LM; Brubaker PL
Endocrinology; 2011 Dec; 152(12):4610-9. PubMed ID: 21971158
[TBL] [Abstract][Full Text] [Related]
7. A human cellular model for studying the regulation of glucagon-like peptide-1 secretion.
Reimer RA; Darimont C; Gremlich S; Nicolas-Métral V; Rüegg UT; Macé K
Endocrinology; 2001 Oct; 142(10):4522-8. PubMed ID: 11564718
[TBL] [Abstract][Full Text] [Related]
8. Cooperative enhancement of insulinotropic action of GLP-1 by acetylcholine uncovers paradoxical inhibitory effect of beta cell muscarinic receptor activation on adenylate cyclase activity.
Miguel JC; Abdel-Wahab YH; Green BD; Mathias PC; Flatt PR
Biochem Pharmacol; 2003 Jan; 65(2):283-92. PubMed ID: 12504804
[TBL] [Abstract][Full Text] [Related]
9. Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion.
Rocca AS; Brubaker PL
Endocrinology; 1999 Apr; 140(4):1687-94. PubMed ID: 10098504
[TBL] [Abstract][Full Text] [Related]
10. Expression of cholecystokinin2-receptor in rat and human L cells and the stimulation of glucagon-like peptide-1 secretion by gastrin treatment.
Cao Y; Cao X; Liu XM
Acta Histochem; 2015 Mar; 117(2):205-10. PubMed ID: 25601282
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum.
Hansen L; Hartmann B; Mineo H; Holst JJ
Regul Pept; 2004 Apr; 118(1-2):11-8. PubMed ID: 14759551
[TBL] [Abstract][Full Text] [Related]
12. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1.
Katsuma S; Hirasawa A; Tsujimoto G
Biochem Biophys Res Commun; 2005 Apr; 329(1):386-90. PubMed ID: 15721318
[TBL] [Abstract][Full Text] [Related]
13. What do we know about the secretion and degradation of incretin hormones?
Deacon CF
Regul Pept; 2005 Jun; 128(2):117-24. PubMed ID: 15780431
[TBL] [Abstract][Full Text] [Related]
14. Regulation of glucagon-like peptide-1-(7-36) amide secretion by intestinal neurotransmitters and hormones in the isolated vascularly perfused rat colon.
Plaisancie P; Bernard C; Chayvialle JA; Cuber JC
Endocrinology; 1994 Dec; 135(6):2398-403. PubMed ID: 7988423
[TBL] [Abstract][Full Text] [Related]
15. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells.
Cembala TM; Sherwin JD; Tidmarsh MD; Appadu BL; Lambert DG
Br J Pharmacol; 1998 Nov; 125(5):1088-94. PubMed ID: 9846649
[TBL] [Abstract][Full Text] [Related]
16. Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum.
Dumoulin V; Dakka T; Plaisancie P; Chayvialle JA; Cuber JC
Endocrinology; 1995 Nov; 136(11):5182-8. PubMed ID: 7588257
[TBL] [Abstract][Full Text] [Related]
17. Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell.
Lim GE; Huang GJ; Flora N; LeRoith D; Rhodes CJ; Brubaker PL
Endocrinology; 2009 Feb; 150(2):580-91. PubMed ID: 18818290
[TBL] [Abstract][Full Text] [Related]
18. Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line.
Drucker DJ; Jin T; Asa SL; Young TA; Brubaker PL
Mol Endocrinol; 1994 Dec; 8(12):1646-55. PubMed ID: 7535893
[TBL] [Abstract][Full Text] [Related]
19. Aberrant regulation of human intestinal proglucagon gene expression in the NCI-H716 cell line.
Cao X; Flock G; Choi C; Irwin DM; Drucker DJ
Endocrinology; 2003 May; 144(5):2025-33. PubMed ID: 12697711
[TBL] [Abstract][Full Text] [Related]
20. Dietary lipids and sweeteners regulate glucagon-like peptide-2 secretion.
Sato S; Hokari R; Kurihara C; Sato H; Narimatsu K; Hozumi H; Ueda T; Higashiyama M; Okada Y; Watanabe C; Komoto S; Tomita K; Kawaguchi A; Nagao S; Miura S
Am J Physiol Gastrointest Liver Physiol; 2013 Apr; 304(8):G708-14. PubMed ID: 23370677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
